PlainPharmaWatch

CMS Open Payments · Program Year 2024

Cosette Pharmaceuticals Inc.

Cosette Pharmaceuticals Inc. reported $1,106.70 across General Payments, Research, and Ownership to 59 physicians and teaching hospitals across 59 transactions.

See the rankings → How this is sourced
$1.1K Below-median payer
All-tracks total
59 Below-median volume
Transactions
59 Below-median reach
Recipients
#1839
of 1,925 companies

Cosette Pharmaceuticals Inc. reported $1,106.70 across all CMS Open Payments tracks (General + Research + Ownership) to 59 physicians and teaching hospitals in Program Year 2024 - ranking #1839 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,106.70, averaging $18.76 per recipient.

Cosette Pharmaceuticals Inc.'s payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

10/100

Total payments

F

10/100

Transaction volume

F

10/100

Physician reach

F

10/100

Payment type diversity

F

10/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer cosette-pharmaceuticals-inc Cosette Pharmaceuticals Inc.

$1.1K · #1839/1,925 · 0.0% industry · PY2024

  • TOT $1.1K
  • RANK #1839
  • SHARE 0.0%
  • TXN 59
  • RCP 59
  • CAT 1
  • GEN $1.1K
  • TOP1 3.4%
  • PY 2024

Volume peers

Nearest volume peer: Civica, Inc. ($1.1K)

GastroKlenz, Inc. DBA CloudC…$1.2KLabcorp Holdings Inc.$1.2KCivica, Inc.$1.1KCosette Pharmaceuticals Inc.…$1.1KSagent Pharmaceuticals$1.0K
All-tracks payment totals near Cosette Pharmaceuticals Inc. (CMS Open Payments PY2024)

Cosette Pharmaceuticals Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Cosette Pharmaceuticals Inc.

CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Cosette Pharmaceuticals Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.

The 1-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $1.1K, accounting for 100.0% of this company's General Payments and 59 transactions.

General Payment Breakdown by Type

"Food and Beverage" leads Cosette Pharmaceuticals Inc.'s 1-category general-payment breakdown at $1.1K, 100.0% of the reported total.

How Cosette Pharmaceuticals Inc. divides its payments

General-payment categories, ordered by reported total

1. Food and Beverage$1.1K
Payment Type Amount Transactions
Food and Beverage $1.1K 59

Recipient Concentration in General Payments

The five largest recipient relationships account for $145.42 (13.1%) of $1,106.70 in this company's General Payments records across 57 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Cosette Pharmaceuticals Inc.

The five named recipients with the highest reported General Payments from this company

Andrea Rollins$37.46Shenelle Wilson$35.68Habib Dalhoumi$24.36Mijin Do$24.12Sameena Rahman$23.80
  1. 1

    Andrea Rollins

    $37.46 across 2 reported transactions

  2. 2

    Shenelle Wilson

    $35.68 across 2 reported transactions

  3. 3

    Habib Dalhoumi

    $24.36 across 1 reported transactions

  4. 4

    Mijin Do

    $24.12 across 1 reported transactions

  5. 5

    Sameena Rahman

    $23.80 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

Cosette Pharmaceuticals Inc.'s spend rank (#1839 of 1,925, bottom 5% by spend) and concentration rank (#1,574 of 1,838, bottom 14% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.

01.83.75.57.3179.3183.2187190.8194.7Total payments ($M)Concentration (HHI, 0-10,000)
Cosette Pharmaceuticals Inc. (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Cosette Pharmaceuticals Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Cosette Pharmaceuticals Inc..

Leica Microsystems Inc.

HHI 183

NeurAxis, Inc.

HHI 182

Mozarc Medical US LLC

HHI 182

Smoky Mountain Surgical Llc

HHI 181

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Cosette Pharmaceuticals Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

Cosette Pharmaceuticals Inc. ranks #1839 of 1,925 by all-tracks total payments, led by "Food and Beverage".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Cosette Pharmaceuticals Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.